Fresenius Medical Care (FMS) revenue breakdown

Healthcare · Medical Care Facilities · Market cap $11.5B

By segment, Care Delivery is the largest at 67% of fiscal 2025 revenue; Value-Based Care grew fastest, 33% a year over 2 years.

By product, Healthcare services is the largest at 67% of fiscal 2025 revenue; Insurance contracts grew fastest, 31% a year over 2 years.

Revenue by segment

Fiscal years, as Fresenius Medical Care reports them in its 10-K filings; fiscal 2025 total $19.6B.

Segments2016201720182019202020212022202320242025Share
Care Delivery—————$14.0B$15.6B$14.3B$13.5B$13.2B 67%
Care Enablement—————$3.6B$3.8B$3.9B$4.1B$4.1B 21%
Value-Based Care———————$1.3B$1.8B$2.2B 11%
North America Segment$12.0B$12.9B$11.6B$12.2B$12.5B————— —
EMEA Segment$2.4B$2.5B$2.6B$2.7B$2.8B————— —
Asia-Pacific Segment$1.5B$1.6B$1.7B$1.9B$1.9B————— —
Latin America Segment$644M$720M$686M$709M$684M————— —
Corporate—$15M$15M$20M$40M————— —

Revenue by product

Fiscal years, as Fresenius Medical Care reports them in its 10-K filings; fiscal 2025 total $19.6B.

Products20212022202320242025Share
Healthcare services$13.9B$15.4B$14.2B$13.5B$13.1B 67%
Healthcare products$3.7B$4.0B$4.1B$4.3B$4.4B 22%
Insurance contracts——$1.2B$1.6B$2.1B 11%

Revenue by region

Fiscal years, as Fresenius Medical Care reports them in its 10-K filings; fiscal 2025 total $19.6B.

Regions201720182019202020212022202320242025Share
Rest of the World$4.5B$4.6B$4.8B$4.9B$5.2B$5.5B$19.0B$18.9B$19.1B 97%
Germany$433M$426M$475M$493M$511M$487M$484M$479M$495M 3%
United States————$12.0B$13.4B——— —
North America$12.9B$11.6B$12.2B$12.5B————— —
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for FMS.
Open FMS in Investingly

Questions

Where does Fresenius Medical Care make its money?

In fiscal 2025, by segment: Care Delivery $13.2B, Care Enablement $4.1B, Value-Based Care $2.2B.

From Fresenius Medical Care's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.